CRH vs ACTH: How the Stress Axis Signals

CRH and ACTH are not rival compounds. They are consecutive steps in one hormonal relay. The hypothalamus releases corticotropin releasing hormone (CRH), the anterior pituitary responds by releasing adrenocorticotropic hormone (ACTH), and the adrenal cortex responds to ACTH by producing cortisol. That three tier arrangement is what endocrinology calls the hypothalamic pituitary adrenal (HPA) axis, and the historical review of the axis describes how each of these components was identified and placed in sequence over the twentieth century (PMID 29719288).

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about your own health, symptoms, hormone results or testing. Nothing here is guidance to use, obtain or administer anything.

The Plain Language Version

Picture a chain of command with three links. The hypothalamus sits at the top as the brain region that integrates signals about threat, inflammation, blood pressure and time of day. When it decides output is needed, it secretes CRH into a short private blood supply that runs down to the anterior pituitary. CRH does not travel through the general circulation to the adrenals; its job is local and specific, and it ends at the pituitary.

The pituitary is the middle link. Corticotroph cells there read the CRH signal and release ACTH into the general bloodstream. ACTH is the messenger that actually travels the distance, reaching the adrenal glands above each kidney.

The adrenal cortex is the third link. Under ACTH stimulation it synthesises and releases cortisol, the principal glucocorticoid in humans. Cortisol then circulates widely, and part of what it does is shut the chain down again by acting back on the pituitary and the hypothalamus. The detailed anatomy of that negative feedback, including the fast and delayed components and the receptor types involved, is the subject of a dedicated physiology review of HPA axis feedback control (PMID 26140713).

So the comparison question "CRH vs ACTH" is really a question about position in a sequence. CRH is the upstream brain signal. ACTH is the downstream blood borne signal. Measuring or stimulating one tells a researcher something different from measuring or stimulating the other, which is the whole logic of the CRH stimulation test described later on this page.

CRH and CRF Are the Same Peptide

One naming point causes recurring confusion. CRH (corticotropin releasing hormone) and CRF (corticotropin releasing factor) refer to the identical 41 amino acid peptide. The older physiology literature used the word "factor" for a hypothalamic substance whose chemical identity had not yet been settled, and switched to "hormone" once the structure was known. Both names persist. Neuroscience papers often prefer CRF; clinical endocrinology papers often prefer CRH. The historical account of how hypothalamic releasing substances were characterised and renamed covers this transition in terminology (PMID 29719288).

There is no biochemical difference implied by the two abbreviations. A receptor described as CRF1 is the same protein as one described as CRHR1. A page comparing "CRH vs CRF" is therefore comparing two labels for one molecule, not two molecules.

Side by Side: CRH Compared With ACTH

The Biochemistry, Step by Step

Step one: CRH release and receptor binding

CRH is produced by neurons in the paraventricular nucleus of the hypothalamus and secreted from their terminals into the hypophyseal portal vessels. It binds CRH receptors on pituitary corticotrophs, which are class B G protein coupled receptors that couple predominantly to adenylate cyclase and raise intracellular cyclic AMP. CRH is not the only input to the corticotroph; vasopressin acts as a co secretagogue, and comparative endocrinology work on the vasotocinergic system in birds describes how vasotocin, the avian counterpart of vasopressin, participates alongside CRH in driving the stress response at the pituitary level (PMID 32138948).

Step two: POMC processing and ACTH release

ACTH is not synthesised as a standalone gene product. It is cleaved from proopiomelanocortin, a larger precursor that also yields other peptide fragments. Rising cyclic AMP in the corticotroph increases POMC transcription and drives release of stored ACTH into the systemic circulation. Because ACTH enters the general bloodstream, its concentration can be sampled from a peripheral vein, which is why it is the practical readout of pituitary activity in research protocols.

Step three: adrenal response

ACTH binds the melanocortin 2 receptor on cells of the adrenal cortex. The downstream effect is mobilisation of cholesterol to the mitochondria and acceleration of steroidogenesis, ending in cortisol secretion. Sustained ACTH exposure also has a trophic effect on the adrenal cortex, while loss of ACTH drive leads to cortical atrophy, a relationship that sits at the centre of how adrenal insufficiency is classified as primary, secondary or tertiary.

Step four: feedback

Cortisol restrains its own production. The review of HPA axis feedback control sets out the multiple levels at which this occurs, from rapid non genomic suppression to slower glucocorticoid receptor mediated changes in gene expression at the pituitary and hypothalamus (PMID 26140713). Feedback is why a single measurement of any one hormone is hard to interpret without the others: a low ACTH value means something very different when cortisol is high than when cortisol is low.

Signalling within the axis is not limited to classical hormone diffusion. A review in Neuroendocrinology examined extracellular vesicles as additional carriers of information within the stress system, describing them as a route by which cells of the axis exchange molecular cargo (PMID 36137504).

How the CRH Stimulation Test Is Described in Published Research

The functional logic of the test follows directly from the anatomy above. Synthetic CRH is administered, and ACTH and cortisol are then sampled over time. Because CRH acts at the pituitary, the shape of the ACTH response reports on pituitary corticotroph responsiveness, while the cortisol response reports on whether the adrenal can follow. A blunted ACTH response with CRH points to a different level of the axis than a preserved ACTH response followed by a weak cortisol rise. This logic of localising a defect to hypothalamus, pituitary or adrenal is part of how the axis has been studied since its components were characterised (PMID 29719288).

Research groups have used CRH stimulation and related dynamic testing to characterise axis behaviour in defined populations. A review of HPA dysfunction in cholestatic liver disease examined evidence of altered axis function in that patient group, including adrenal insufficiency in the context of liver disease (PMID 30483216). A review of neuroendocrine dysfunction in Sjogren's syndrome reported evidence of altered hypothalamic pituitary adrenal responses in that autoimmune condition (PMID 18667798). A Dutch language review of neuroendocrine correlates of burnout surveyed HPA axis measures studied in burnout research (PMID 22753184).

Psychiatric research has used the same framework. A review of the biology of posttraumatic stress disorder discussed HPA axis alterations, including findings on CRH and cortisol regulation in that disorder (PMID 11495096). Separately, work on hypercortisolemia and depression examined the relationship between elevated cortisol and depressive illness (PMID 15953796). None of these publications constitutes guidance for any individual, and none of this page interprets anyone's results.

Things That Modify the Signal

The CRH to ACTH to cortisol relay is not a closed loop. Immune signals, drugs and chronic load all enter it. Research on chronic stress and an interleukin 10 mediated immunoregulatory loop in periodontitis examined how stress axis activity intersects with immune regulation in that disease model (PMID 41289041). On the pharmacological side, a review of endocrine effects of antiepileptic drugs surveyed hormonal changes associated with those medications (PMID 19205363), and a paper in Neuroscience Letters discussed HPA axis targets in relation to epilepsy, including interest in CRH receptor and glucocorticoid signalling as research targets (PMID 33429002). These are descriptions of research directions, not statements that anything works.

Common Points of Confusion: What Studies Report

This section covers conceptual errors rather than adverse events, since this page describes signalling biology rather than an intervention.

• "CRH and ACTH do the same thing." They act on different receptors in different tissues. CRH acts on CRH receptors at the pituitary; ACTH acts on the melanocortin 2 receptor at the adrenal cortex.
• "CRH stimulates the adrenal gland." The adrenal response to CRH in an intact system is indirect, mediated by the ACTH that CRH releases.
• "CRF is a weaker form of CRH." They are the same 41 amino acid peptide under two historical names, a terminology shift traced in the history of the axis (PMID 29719288).
• "A single hormone value identifies where a problem is." Because of layered feedback, interpretation depends on paired values and on dynamic testing, as the feedback control review describes (PMID 26140713).

What This Page Does Not Do

It does not interpret laboratory results, suggest testing, describe how any substance should be used, or offer advice about managing stress. Hormone results and symptoms belong in a conversation with a licensed physician who can see the full clinical picture. Readers wanting more depth on each peptide individually can continue to the dedicated ACTH and CRH pages.

References

• The Hypothalamic-Pituitary-Adrenal Axis: A Brief History (Hormone Research in Paediatrics, 2018)
• Hypothalamic-Pituitary-Adrenal Axis-Feedback Control (Comprehensive Physiology, 2015)
• Extracellular Vesicles and the Stress System (Neuroendocrinology, 2023)
• Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease (Frontiers in Endocrinology, 2018)
• Neuro-endocrine correlates of burnout (Tijdschrift voor Psychiatrie, 2012)
• Endocrine effects of antiepileptic drugs (Przeglad Lekarski, 2008)
• Biology of posttraumatic stress disorder (The Journal of Clinical Psychiatry, 2001)
• Hypercortisolemia and depression (Psychosomatic Medicine, 2005)
• Neuroendocrine dysfunction in Sjogren's syndrome (Neuroimmunomodulation, 2008)
• Chronic stress and the IL-10-mediated immunoregulatory loop in the pathogenesis of periodontitis (Clinical Science, 2025)
• The vasotocinergic system and its role in the regulation of stress in birds (Vitamins and Hormones, 2020)
• Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy (Neuroscience Letters, 2021)